Last 12 months
Inside the activity.
0 purchase rows · 35 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 8 |
| Dec 2025 | 0 | 2 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 16 |
| Mar 2026 | 0 | 3 |
| Apr 2026 | 0 | 2 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 30, 2022 Filed Mar 31, 2022 14:46 UTC |
HANLY ANN M.Chief Technology Officer
|
SaleCommon Stock | 2,627 | $26.24 | $68,925.39 |
DisclosureSEC source: 0001209191-22-021728 · doc4.xml · nonDerivative · entry 1 HANLY ANN M. · CIK 0001854528 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,473 F1 · kind: Represents the automatic sale of shares to cover the Issuer's tax withholding and remittance obligation in connection with the vesting of restricted stock units. Read SEC document |
| March 10, 2022 Filed Mar 11, 2022 21:04 UTC |
Virgin HerbertEVP, Research & CSO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 9,000 | $0.00 Strike: $1.53 | $0.00 |
DisclosureSEC source: 0001209191-22-018153 · doc4.xml · derivative · entry 2 Virgin Herbert · CIK 0001786378 · EVP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 210,505 Underlying: Common Stock · 9,000 shares Expires 2028-01-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| March 10, 2022 Filed Mar 11, 2022 21:04 UTC |
Virgin HerbertEVP, Research & CSO
|
Exercise / conversionCommon Stock | 9,000 | $1.53 | $13,770.00 |
DisclosureSEC source: 0001209191-22-018153 · doc4.xml · nonDerivative · entry 1 Virgin Herbert · CIK 0001786378 · EVP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 184,407 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 10, 2022 Filed Apr 6, 2022 21:22 UTC |
SCANGOS GEORGE ADirector · President and CEO
|
GrantStock Option (Right to Buy) · Derivative | 222,000 | $0.00 Strike: $29.48 | $0.00 |
DisclosureSEC source: 0001209191-22-023524 · doc4.xml · derivative · entry 8 SCANGOS GEORGE A · CIK 0001202102 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 222,000 Underlying: Common Stock · 222,000 shares Expires 2032-03-09 F8 · derivative.exercise_date: 25% of the shares subject to the stock option vest and become exercisable on February 22, 2023, and the remainder vest in 36 equal monthly installments thereafter. Read SEC document |
| March 10, 2022 Filed Apr 6, 2022 21:22 UTC |
SCANGOS GEORGE ADirector · President and CEO
|
GrantCommon Stock | 111,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-023524 · doc4.xml · nonDerivative · entry 1 SCANGOS GEORGE A · CIK 0001202102 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 223,989 F1 · kind: Acquisition of restricted stock units pursuant to the Issuer's Equity Incentive Plan. Read SEC document |
| March 02, 2022 Filed Mar 8, 2022 16:35 UTC |
Friedl-Naderer JohannaChief Business Officer, Global
|
GrantStock Option (Right to Buy) · Derivative | 45,000 | $0.00 Strike: $24.13 | $0.00 |
DisclosureSEC source: 0001209191-22-016929 · doc4.xml · derivative · entry 2 Friedl-Naderer Johanna · CIK 0001915598 · Chief Business Officer, Global 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 45,000 shares Expires 2032-03-01 F2 · derivative.exercise_date: 25% of the shares subject to the stock option vest and become exercisable on March 2, 2023, and the remainder vest in 36 equal monthly installments thereafter. Read SEC document |
| March 02, 2022 Filed Mar 8, 2022 16:35 UTC |
Friedl-Naderer JohannaChief Business Officer, Global
|
GrantCommon Stock | 90,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-016929 · doc4.xml · nonDerivative · entry 1 Friedl-Naderer Johanna · CIK 0001915598 · Chief Business Officer, Global 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,000 F1 · kind: Acquisition of restricted stock units pursuant to the Issuer's Equity Incentive Plan. Read SEC document |
| February 22, 2022 Filed Feb 24, 2022 21:33 UTC |
HANLY ANN M.Chief Technology Officer
|
GrantStock Option (Right to Buy) · Derivative | 47,000 | $0.00 Strike: $29.48 | $0.00 |
DisclosureSEC source: 0001209191-22-012955 · doc4.xml · derivative · entry 3 HANLY ANN M. · CIK 0001854528 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,000 Underlying: Common Stock · 47,000 shares Expires 2032-02-21 F3 · derivative.exercise_date: 25% of the shares subject to the stock option vest and become exercisable on February 22, 2023, and the remainder vest in 36 equal monthly installments thereafter. Read SEC document |
| February 22, 2022 Filed Feb 24, 2022 21:33 UTC |
HANLY ANN M.Chief Technology Officer
|
GrantCommon Stock | 53,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-012955 · doc4.xml · nonDerivative · entry 1 HANLY ANN M. · CIK 0001854528 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,100 F1 · kind: Acquisition of restricted stock units pursuant to the Issuer's Equity Incentive Plan. Read SEC document |
| February 22, 2022 Filed Feb 25, 2022 02:33 UTC |
Pang PhillipChief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 64,000 | $0.00 Strike: $29.48 | $0.00 |
DisclosureSEC source: 0001209191-22-012954 · doc4.xml · derivative · entry 2 Pang Phillip · CIK 0001787370 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,000 Underlying: Common Stock · 64,000 shares Expires 2032-02-21 F2 · derivative.exercise_date: 25% of the shares subject to the stock option vest and become exercisable on February 22, 2023, and the remainder vest in 36 equal monthly installments thereafter. Read SEC document |
| February 22, 2022 Filed Feb 25, 2022 02:33 UTC |
Pang PhillipChief Medical Officer
|
GrantCommon Stock | 67,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-012954 · doc4.xml · nonDerivative · entry 1 Pang Phillip · CIK 0001787370 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 156,768 F1 · kind: Acquisition of restricted stock units pursuant to the Issuer's Equity Incentive Plan. Read SEC document |
| February 22, 2022 Filed Feb 25, 2022 02:31 UTC |
Rice Steven J.Chief Administrative Officer
|
GrantStock Option (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $29.48 | $0.00 |
DisclosureSEC source: 0001209191-22-012953 · doc4.xml · derivative · entry 2 Rice Steven J. · CIK 0001820108 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2032-02-21 F2 · derivative.exercise_date: 25% of the shares subject to the stock option vest and become exercisable on February 22, 2023, and the remainder vest in 36 equal monthly installments thereafter. Read SEC document |
| February 22, 2022 Filed Feb 25, 2022 02:31 UTC |
Rice Steven J.Chief Administrative Officer
|
GrantCommon Stock | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-012953 · doc4.xml · nonDerivative · entry 1 Rice Steven J. · CIK 0001820108 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,658 F1 · kind: Acquisition of restricted stock units pursuant to the Issuer's Equity Incentive Plan. Read SEC document |
| February 22, 2022 Filed Feb 25, 2022 02:30 UTC |
Virgin HerbertEVP, Research & CSO
|
GrantStock Option (Right to Buy) · Derivative | 70,000 | $0.00 Strike: $29.48 | $0.00 |
DisclosureSEC source: 0001209191-22-012952 · doc4.xml · derivative · entry 5 Virgin Herbert · CIK 0001786378 · EVP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,000 Underlying: Common Stock · 70,000 shares Expires 2032-02-21 F4 · derivative.exercise_date: 25% of the shares subject to the stock option vest and become exercisable on February 22, 2023, and the remainder vest in 36 equal monthly installments thereafter. Read SEC document |
| February 22, 2022 Filed Feb 25, 2022 02:30 UTC |
Virgin HerbertEVP, Research & CSO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,375 | $0.00 Strike: $1.53 | $0.00 |
DisclosureSEC source: 0001209191-22-012952 · doc4.xml · derivative · entry 4 Virgin Herbert · CIK 0001786378 · EVP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 219,505 Underlying: Common Stock · 1,375 shares Expires 2028-01-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| February 22, 2022 Filed Feb 25, 2022 02:30 UTC |
Virgin HerbertEVP, Research & CSO
|
SaleCommon Stock | 1,375 | $30.00 | $41,250.00 |
DisclosureSEC source: 0001209191-22-012952 · doc4.xml · nonDerivative · entry 3 Virgin Herbert · CIK 0001786378 · EVP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 175,407 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 26, 2021. Read SEC document |
| February 22, 2022 Filed Feb 25, 2022 02:30 UTC |
Virgin HerbertEVP, Research & CSO
|
Exercise / conversionCommon Stock | 1,375 | $1.53 | $2,103.75 |
DisclosureSEC source: 0001209191-22-012952 · doc4.xml · nonDerivative · entry 2 Virgin Herbert · CIK 0001786378 · EVP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 176,782 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 22, 2022 Filed Feb 25, 2022 02:30 UTC |
Virgin HerbertEVP, Research & CSO
|
GrantCommon Stock | 70,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-012952 · doc4.xml · nonDerivative · entry 1 Virgin Herbert · CIK 0001786378 · EVP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 175,407 F1 · kind: Acquisition of restricted stock units pursuant to the Issuer's Equity Incentive Plan. Read SEC document |
| February 22, 2022 Filed Feb 25, 2022 02:29 UTC |
Horn HowardCFO
|
GrantStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $29.48 | $0.00 |
DisclosureSEC source: 0001209191-22-012951 · doc4.xml · derivative · entry 2 Horn Howard · CIK 0001786335 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2032-02-21 F2 · derivative.exercise_date: 25% of the shares subject to the stock option vest and become exercisable on February 22, 2023, and the remainder vest in 36 equal monthly installments thereafter. Read SEC document |
| February 22, 2022 Filed Feb 25, 2022 02:29 UTC |
Horn HowardCFO
|
GrantCommon Stock | 35,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-012951 · doc4.xml · nonDerivative · entry 1 Horn Howard · CIK 0001786335 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 235,384 F1 · kind: Acquisition of restricted stock units pursuant to the Issuer's Equity Incentive Plan. Read SEC document |
| February 18, 2022 Filed Feb 22, 2022 22:01 UTC |
SCANGOS GEORGE ADirector · President and CEO
|
SaleCommon Stock | 17,726 | $30.65 | $543,303.67 |
DisclosureSEC source: 0001209191-22-011756 · doc4.xml · nonDerivative · entry 2 SCANGOS GEORGE A · CIK 0001202102 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,989 F2 · kind: Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 24, 2021. F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.95 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 17, 2022 Filed Feb 18, 2022 21:47 UTC |
Pang PhillipChief Medical Officer
|
SaleCommon Stock | 3,009 | $31.93 | $96,079.78 |
DisclosureSEC source: 0001209191-22-011338 · doc4.xml · nonDerivative · entry 3 Pang Phillip · CIK 0001787370 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,768 F2 · kind: Represents the automatic sale of shares to cover the Issuer's tax withholding and remittance obligation in connection with the vesting of restricted stock units. Read SEC document |
| February 17, 2022 Filed Feb 22, 2022 22:02 UTC |
Virgin HerbertEVP, Research & CSO
|
SaleCommon Stock | 2,293 | $31.93 | $73,217.55 |
DisclosureSEC source: 0001209191-22-011755 · doc4.xml · nonDerivative · entry 1 Virgin Herbert · CIK 0001786378 · EVP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,407 F1 · kind: Represents the automatic sale of shares to cover the Issuer's tax withholding and remittance obligation in connection with the vesting of restricted stock units. Read SEC document |
| February 17, 2022 Filed Feb 22, 2022 22:01 UTC |
SCANGOS GEORGE ADirector · President and CEO
|
SaleCommon Stock | 10,024 | $31.93 | $320,074.34 |
DisclosureSEC source: 0001209191-22-011756 · doc4.xml · nonDerivative · entry 1 SCANGOS GEORGE A · CIK 0001202102 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,715 F1 · kind: Represents the automatic sale of shares to cover the Issuer's tax withholding and remittance obligation in connection with the vesting of restricted stock units. Read SEC document |
| February 17, 2022 Filed Feb 22, 2022 22:01 UTC |
Rice Steven J.Chief Administrative Officer
|
SaleCommon Stock | 1,942 | $31.93 | $62,010.39 |
DisclosureSEC source: 0001209191-22-011750 · doc4.xml · nonDerivative · entry 1 Rice Steven J. · CIK 0001820108 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,658 F1 · kind: Represents the automatic sale of shares to cover the Issuer's tax withholding and remittance obligation in connection with the vesting of restricted stock units. Read SEC document |
| February 17, 2022 Filed Feb 22, 2022 22:00 UTC |
Horn HowardCFO
|
SaleCommon Stock | 2,393 | $31.93 | $76,410.64 |
DisclosureSEC source: 0001209191-22-011735 · doc4.xml · nonDerivative · entry 1 Horn Howard · CIK 0001786335 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,384 F1 · kind: Represents the automatic sale of shares to cover the Issuer's tax withholding and remittance obligation in connection with the vesting of restricted stock units. Read SEC document |
| February 16, 2022 Filed Feb 18, 2022 21:47 UTC |
Pang PhillipChief Medical Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $1.53 | $0.00 |
DisclosureSEC source: 0001209191-22-011338 · doc4.xml · derivative · entry 4 Pang Phillip · CIK 0001787370 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,591 Underlying: Common Stock · 5,000 shares Expires 2028-04-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 1/4 of the shares subject to the stock option vested and became exercisable on April 27, 2019, and the remaining shares vest in 36 equal monthly installments thereafter. Read SEC document |
| February 16, 2022 Filed Feb 18, 2022 21:47 UTC |
Pang PhillipChief Medical Officer
|
SaleCommon Stock | 5,000 | $31.54 | $157,700.00 |
DisclosureSEC source: 0001209191-22-011338 · doc4.xml · nonDerivative · entry 2 Pang Phillip · CIK 0001787370 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,777 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 19, 2021. Read SEC document |
| February 16, 2022 Filed Feb 18, 2022 21:47 UTC |
Pang PhillipChief Medical Officer
|
Exercise / conversionCommon Stock | 5,000 | $1.53 | $7,650.00 |
DisclosureSEC source: 0001209191-22-011338 · doc4.xml · nonDerivative · entry 1 Pang Phillip · CIK 0001787370 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,777 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 08, 2022 Filed Feb 9, 2022 23:58 UTC |
Virgin HerbertEVP, Research & CSO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,375 | $0.00 Strike: $1.53 | $0.00 |
DisclosureSEC source: 0001209191-22-008208 · doc4.xml · derivative · entry 3 Virgin Herbert · CIK 0001786378 · EVP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 220,880 Underlying: Common Stock · 1,375 shares Expires 2028-01-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| February 08, 2022 Filed Feb 9, 2022 23:58 UTC |
Virgin HerbertEVP, Research & CSO
|
SaleCommon Stock | 1,375 | $33.94 | $46,667.50 |
DisclosureSEC source: 0001209191-22-008208 · doc4.xml · nonDerivative · entry 2 Virgin Herbert · CIK 0001786378 · EVP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,700 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 26, 2021. Read SEC document |
| February 08, 2022 Filed Feb 9, 2022 23:58 UTC |
Virgin HerbertEVP, Research & CSO
|
Exercise / conversionCommon Stock | 1,375 | $1.53 | $2,103.75 |
DisclosureSEC source: 0001209191-22-008208 · doc4.xml · nonDerivative · entry 1 Virgin Herbert · CIK 0001786378 · EVP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,075 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 02, 2022 Filed Feb 4, 2022 22:03 UTC |
Pang PhillipChief Medical Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $1.53 | $0.00 |
DisclosureSEC source: 0001209191-22-007235 · doc4.xml · derivative · entry 3 Pang Phillip · CIK 0001787370 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,591 Underlying: Common Stock · 5,000 shares Expires 2028-04-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 1/4 of the shares subject to the stock option vested and became exercisable on April 27, 2019, and the remaining shares vest in 36 equal monthly installments thereafter. Read SEC document |
| February 02, 2022 Filed Feb 4, 2022 22:03 UTC |
Pang PhillipChief Medical Officer
|
SaleCommon Stock | 5,000 | $34.52 | $172,619.50 |
DisclosureSEC source: 0001209191-22-007235 · doc4.xml · nonDerivative · entry 2 Pang Phillip · CIK 0001787370 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,777 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 19, 2021. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.13 to $35.04 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 02, 2022 Filed Feb 4, 2022 22:03 UTC |
Pang PhillipChief Medical Officer
|
Exercise / conversionCommon Stock | 5,000 | $1.53 | $7,650.00 |
DisclosureSEC source: 0001209191-22-007235 · doc4.xml · nonDerivative · entry 1 Pang Phillip · CIK 0001787370 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,777 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 25, 2022 Filed Jan 27, 2022 00:35 UTC |
Virgin HerbertEVP, Research & CSO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,375 | $0.00 Strike: $1.53 | $0.00 |
DisclosureSEC source: 0001209191-22-005117 · doc4.xml · derivative · entry 3 Virgin Herbert · CIK 0001786378 · EVP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 222,255 Underlying: Common Stock · 1,375 shares Expires 2028-01-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| January 25, 2022 Filed Jan 27, 2022 00:35 UTC |
Virgin HerbertEVP, Research & CSO
|
SaleCommon Stock | 1,375 | $32.46 | $44,632.50 |
DisclosureSEC source: 0001209191-22-005117 · doc4.xml · nonDerivative · entry 2 Virgin Herbert · CIK 0001786378 · EVP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,700 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 26, 2021. Read SEC document |
| January 25, 2022 Filed Jan 27, 2022 00:35 UTC |
Virgin HerbertEVP, Research & CSO
|
Exercise / conversionCommon Stock | 1,375 | $1.53 | $2,103.75 |
DisclosureSEC source: 0001209191-22-005117 · doc4.xml · nonDerivative · entry 1 Virgin Herbert · CIK 0001786378 · EVP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,075 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 19, 2022 Filed Jan 20, 2022 22:55 UTC |
Pang PhillipChief Medical Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $1.53 | $0.00 |
DisclosureSEC source: 0001209191-22-004143 · doc4.xml · derivative · entry 4 Pang Phillip · CIK 0001787370 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,591 Underlying: Common Stock · 5,000 shares Expires 2028-04-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: 1/4 of the shares subject to the stock option vested and became exercisable on April 27, 2019, and the remaining shares vest in 36 equal monthly installments thereafter. Read SEC document |
| January 19, 2022 Filed Jan 20, 2022 22:55 UTC |
Pang PhillipChief Medical Officer
|
SaleCommon Stock | 2,542 | $35.52 | $90,290.06 |
DisclosureSEC source: 0001209191-22-004143 · doc4.xml · nonDerivative · entry 3 Pang Phillip · CIK 0001787370 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,777 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 19, 2021. F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.13 to $35.865 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 19, 2022 Filed Jan 20, 2022 22:55 UTC |
Pang PhillipChief Medical Officer
|
SaleCommon Stock | 2,458 | $34.59 | $85,014.11 |
DisclosureSEC source: 0001209191-22-004143 · doc4.xml · nonDerivative · entry 2 Pang Phillip · CIK 0001787370 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,319 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 19, 2021. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.12 to $35.06 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 19, 2022 Filed Jan 20, 2022 22:55 UTC |
Pang PhillipChief Medical Officer
|
Exercise / conversionCommon Stock | 5,000 | $1.53 | $7,650.00 |
DisclosureSEC source: 0001209191-22-004143 · doc4.xml · nonDerivative · entry 1 Pang Phillip · CIK 0001787370 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,777 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 18, 2022 Filed Jan 20, 2022 22:01 UTC |
SATO VICKI LDirector
|
SaleCommon Stock | 15,173 | $37.39 | $567,385.23 |
DisclosureSEC source: 0001209191-22-004083 · doc4.xml · nonDerivative · entry 1 SATO VICKI L · CIK 0001197020 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,535,919 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 24, 2021. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.87 to $37.79, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. Read SEC document |
| January 11, 2022 Filed Jan 13, 2022 21:09 UTC |
Virgin HerbertEVP, Research & CSO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,375 | $0.00 Strike: $1.53 | $0.00 |
DisclosureSEC source: 0001209191-22-003175 · doc4.xml · derivative · entry 3 Virgin Herbert · CIK 0001786378 · EVP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 223,630 Underlying: Common Stock · 1,375 shares Expires 2028-01-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| January 11, 2022 Filed Jan 13, 2022 21:09 UTC |
Virgin HerbertEVP, Research & CSO
|
SaleCommon Stock | 1,375 | $35.10 | $48,262.50 |
DisclosureSEC source: 0001209191-22-003175 · doc4.xml · nonDerivative · entry 2 Virgin Herbert · CIK 0001786378 · EVP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,700 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 26, 2021. Read SEC document |
| January 11, 2022 Filed Jan 13, 2022 21:09 UTC |
Virgin HerbertEVP, Research & CSO
|
Exercise / conversionCommon Stock | 1,375 | $1.53 | $2,103.75 |
DisclosureSEC source: 0001209191-22-003175 · doc4.xml · nonDerivative · entry 1 Virgin Herbert · CIK 0001786378 · EVP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,075 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 05, 2022 Filed Jan 7, 2022 00:48 UTC |
Pang PhillipChief Medical Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $1.53 | $0.00 |
DisclosureSEC source: 0001209191-22-002257 · doc4.xml · derivative · entry 4 Pang Phillip · CIK 0001787370 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,591 Underlying: Common Stock · 5,000 shares Expires 2018-04-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 1/4 of the shares subject to the stock option vested and became exercisable on April 27, 2019, and the remaining shares vest in 36 equal monthly installments thereafter. Read SEC document |
| January 05, 2022 Filed Jan 7, 2022 00:48 UTC |
Pang PhillipChief Medical Officer
|
SaleCommon Stock | 400 | $37.78 | $15,112.00 |
DisclosureSEC source: 0001209191-22-002257 · doc4.xml · nonDerivative · entry 3 Pang Phillip · CIK 0001787370 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,777 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 19, 2021. Read SEC document |
| January 05, 2022 Filed Jan 7, 2022 00:48 UTC |
Pang PhillipChief Medical Officer
|
SaleCommon Stock | 4,600 | $37.14 | $170,844.00 |
DisclosureSEC source: 0001209191-22-002257 · doc4.xml · nonDerivative · entry 2 Pang Phillip · CIK 0001787370 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,177 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 19, 2021. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.76 to $37.49 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 05, 2022 Filed Jan 7, 2022 00:48 UTC |
Pang PhillipChief Medical Officer
|
Exercise / conversionCommon Stock | 5,000 | $1.53 | $7,650.00 |
DisclosureSEC source: 0001209191-22-002257 · doc4.xml · nonDerivative · entry 1 Pang Phillip · CIK 0001787370 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,777 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.